Skip to main content
Premium Trial:

Request an Annual Quote

Perlegen to Conduct Second Genotyping Study for AstraZeneca

NEW YORK, Jan. 24 (GenomeWeb News) - Perlegen Sciences will conduct a second genotyping study for AstraZeneca, the Mountain View, Calif.-based company said today.

 

Under the agreement, Perlegen will determine SNPs in individuals with an undisclosed trait of interest as well as in controls.

 

One year ago, the two companies announced their first collaboration to study the genetics of myocardial infarction.

The Scan

Looking for Omicron

NPR reports that SARS-CoV-2 testing in the US has gotten better but also that some experts say more needs to be done to better track the Omicron variant.

Holmes Alleges Abuse

The Associated Press reports that Theranos' Elizabeth Holmes has testified at her wire fraud trial that her business and romantic partner abused her.

Bit More Diverse, But More to Do

While Black and Hispanic patients are more likely to participate in cancer clinical trials than previously, they are still underrepresented, according to US News & World Report.

PNAS Papers on Yeast Gene Silencing, Zika Virus Inhibition, Immunoglobulin Hypermutation

In PNAS this week: gene silencing in Saccharomyces cerevisiae, possible neuroprotective role for SHFL in a mouse model of Zika virus infection, and more.